• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    1/31/24 1:18:09 PM ET
    $AHT
    $AMD
    $AMSC
    $ASH
    Real Estate Investment Trusts
    Real Estate
    Semiconductors
    Technology
    Get the next $AHT alert in real time by email

    Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) shares declined 3.8% to $165.49 following fourth-quarter results.

    AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion.

    AMD shares dipped 3.8% to $165.49 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) shares jumped 204% to $0.6049. Connexa said it has regained compliance with Nasdaq minimum shareholder equity rule.
    • Minim, Inc. (NASDAQ:MINM) shares climbed 76.4% to $4.48. David E. Lazar disclosed a 51% active stake in Minim Inc.
    • Powell Industries, Inc. (NASDAQ:POWL) shares gained 49% to $121.89 after the company reported better-than-expected first-quarter financial results and raised its quarterly dividend.
    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) climbed 46.5% to $0.1180 after falling around 7% on Tuesday.
    • Ashford Hospitality Trust, Inc. (NYSE:AHT) jumped 32% to $1.77.
    • 2seventy bio, Inc. (NASDAQ:TSVT) rose 31.6% to $5.28. 2seventy Bio said it will focus exclusively on commercialization and development of Abecma and sell its R&D pipeline to Regeneron. Leerink Partners analyst Daina Graybosch upgraded 2seventy bio from Market Perform to Outperform and raised the price target from $5 to $18.
    • Trinity Biotech plc (NASDAQ:TRIB) gained 29.5% to $0.5638. Trinity Biotech announced acquisition of the CGM assets of Waveform Technologies, Inc.
    • Kuke Music Holding Limited (NYSE:KUKE) rose 23.7% to $1.25.
    • Vaxart, Inc. (NASDAQ:VXRT) jumped 20.9% to $1.1850. B. Riley Securities analyst Mayank Mamtani upgraded Vaxart from Neutral to Buy and announced a $2 price target.
    • Envirotech Vehicles, Inc. (NASDAQ:EVTV) gained 20.6% to $1.75.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) gained 19.6% to $1.7232. Ensysce Biosciences reported completion of a constructive end of Phase 2 meeting with the FDA regarding its lead 'next generation' analgesic, PF614.
    • Plug Power Inc. (NASDAQ:PLUG) climbed 17.8% to $4.3950 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4.5 to $9.
    • DocGo Inc. (NASDAQ:DCGO) gained 15.8% to $3.9497 after the company announced a share buyback program of up to $36 million.
    • Ashland Inc. (NYSE:ASH) jumped 14.5% to $92.50 after the company reported mixed first-quarter financial results and issued guidance.
    • Jin Medical International Ltd. (NASDAQ:ZJYL) rose 12.5% to $236.64.
    • LendingClub Corporation (NYSE:LC) gained 12.3% to $9.81 after the company reported better-than-expected quarterly financial results.
    • Nomura Holdings, Inc. (NYSE:NMR) rose 12.2% to $5.84 following third-quarter results.
    • Paramount Global (NASDAQ:PARA) gained 10.4% to $15.10. Byron Allen offered $14.3 billion to buy all of the outstanding shares of Paramount Global, Bloomberg reported.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) gained 10.3% to $8.77 after dipping around 39% on Tuesday.
    • Nyxoah S.A. (NASDAQ:NYXH) shares rose 9.1% to $8.88 after dipping 34% on Tuesday.
    • Stryker Corporation (NYSE:SYK) gained 5.8% to $335.28 after the company reported better-than-expected fourth-quarter financial results.

    Losers

    • Nuvve Holding Corp. (NASDAQ:NVVE) shares dipped 65.8% to $1.1401. Nuvve announced pricing of $9.6 million underwritten public offering of 4.8 million shares of common stock at $2.00 per share.
    • Remark Holdings, Inc. (NASDAQ:MARK) shares fell 36% to $0.80. Remark Holdings shares jumped 264% on Tuesday following a Tweet from the company's X account suggesting an unconfirmed deal with Microsoft..
    • New York Community Bancorp, Inc. (NYSE:NYCB) fell 34.5% to $6.80 after the company reported worse-than-expected fourth-quarter financial results and reduced its quarterly dividend.
    • GRI Bio, Inc. (NASDAQ:GRI) fell 28.6% to $2.05.
    • Genprex, Inc. (NASDAQ:GNPX) declined 28% to $0.1931. Genprex announced a 1-for-40 reverse stock split effective Feb. 2, 2024.
    • Evaxion Biotech A/S (NASDAQ:EVAX) fell 24% to $4.3999.
    • TuSimple Holdings Inc. (NASDAQ:TSP) declined 23.4% to $0.2220.
    • Rail Vision Ltd. (NASDAQ:RVSN) fell 21.9% to $11.70.
    • American Superconductor Corporation (NASDAQ:AMSC) shares declined 18.2% to $0.20 after the company announced a proposed public offering of common stock.
    • Extreme Networks, Inc. (NASDAQ:EXTR) fell 15.8% to $14.02 after the company reported mixed second-quarter financial results and issued guidance.
    • Rockwell Automation, Inc. (NYSE:ROK) declined 15.3% to $260.07 following weak earnings.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares fell 14.2% to $0.4067 after jumping 47% on Tuesday.
    • Synaptogenix, Inc. (NASDAQ:SNPX) fell 13% to $0.1864 after gaining 12% on Tuesday.
    • LSB Industries, Inc. (NYSE:LXU) fell 9.5% to $7.51. UBS analyst Joshua Spector downgraded LSB Industries from Buy to Neutral and lowered the price target from $11 to $9.
    • MarketAxess Holdings Inc. (NASDAQ:MKTX) fell 8.8% to $250.01 following weak sales.
    • Teradyne, Inc. (NASDAQ:TER) shares declined 8.2% to $95.99 after the company posted downbeat fourth-quarter sales and issued weak forecast for the first quarter.
    • Oblong, Inc. (NASDAQ:OBLG) declined 8.1% to $0.20 trading after gaining around 24% on Tuesday.
    • Solid Biosciences Inc. (NASDAQ:SLDB) fell 7.5% to $7.47.
    • Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) shares fell 6.2% to $143.60. Alphabet posted better-than-expected earnings results for its fourth quarter on Tuesday. However, Google’s advertising sales came in short of market estimates.
    • Heartland Financial USA, Inc. (NASDAQ:HTLF) fell 5.5% to $36.54.
    • Group 1 Automotive, Inc. (NYSE:GPI) fell 5.5% to $266.64 after the company reported mixed fourth-quarter financial results.
    • Novartis AG (NYSE:NVS) fell around 3% to $104.69 following weak quarterly results.

     

    Now Read This: Bitcoin Falls Below $43,000 Following ADP Report; Blur, Manta Network Among Top Losers

    Get the next $AHT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHT
    $AMD
    $AMSC
    $ASH

    CompanyDatePrice TargetRatingAnalyst
    Advanced Micro Devices Inc.
    $AMD
    4/24/2026$375.00Neutral → Buy
    DA Davidson
    Alphabet Inc.
    $GOOGL
    4/20/2026$370.00 → $380.00Overweight
    KeyBanc Capital Markets
    Advanced Micro Devices Inc.
    $AMD
    4/16/2026$235.00 → $265.00Mkt Perform
    Bernstein
    Alphabet Inc.
    $GOOGL
    4/14/2026$390.00 → $405.00Buy
    Citigroup
    Stryker Corporation
    $SYK
    4/13/2026$410.00Outperform
    Leerink Partners
    Alphabet Inc.
    $GOOGL
    4/10/2026$410.00 → $420.00Outperform
    Mizuho
    Alphabet Inc.
    $GOOGL
    4/10/2026$390.00 → $360.00Outperform
    Wolfe Research
    MarketAxess Holdings Inc.
    $MKTX
    4/8/2026$195.00Outperform
    Keefe Bruyette
    More analyst ratings

    $AHT
    $AMD
    $AMSC
    $ASH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 1, 2024 - FDA Roundup: November 1, 2024

    For Immediate Release: November 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “FDA Takes Exciting Steps Toward Establishing the Rare Disease Innovation Hub,” by Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER) and Peter Marks, M.D., Ph.D., director

    11/1/24 3:18:19 PM ET
    $NVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)

    PHILADELPHIA, April 24, 2026 (GLOBE NEWSWIRE) -- National plaintiffs' law firm Berger Montague PC advises shareholders of Stryker Corporation (NYSE:SYK) ("Stryker" or the "Company") about an investigation into Stryker's Board of Directors (the "Board") for potential breaches of fiduciary duties owed to the Company and its shareholders. The investigation focuses on whether the Board failed to exercise appropriate oversight regarding its cybersecurity and data protection practices, including the Company's response to a recent cyber incident affecting its operations and data environment. Shareholders of Stryker may learn more about this investigation by contacting Berger Montague: Andrew Abr

    4/24/26 8:50:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

    Appointment strengthens Board's clinical development and regulatory expertise as Vaxart advances its oral vaccine platform SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX:VXRT), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary delivery platform, today announced the appointment of James Breitmeyer, M.D., Ph.D., to its Board of Directors. Dr. Breitmeyer brings more than 35 years of biopharmaceutical experience, having led clinical development programs resulting in eight FDA product approvals and numerous regulatory successes across the United States, Europe, and Japan. "We are pleased to welcome Jim to t

    4/23/26 4:30:00 PM ET
    $VXRT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    City of Socorro Awarded State Funding for Grid Modernization Project in Partnership with Socorro Electric Cooperative and Nuvve

    The City of Socorro has been awarded $610,000 in funding from the State of New Mexico's Energy Conservation and Management Division (ECAM) to advance a grid modernization initiative aimed at improving reliability, resilience, and long-term energy infrastructure planning. The funding allows Socorro Electric Cooperative (SEC) and Nuvve New Mexico to design and engineer a utility-scale battery energy storage system (BESS) and associated grid upgrades. The ECAM award supports a Type 2 Grid Modernization project, which includes feasibility analysis, system design, interconnection planning, and economic modeling. The effort establishes a pathway toward a future deployment phase, which is a plan

    4/23/26 9:00:00 AM ET
    $NVVE
    Electrical Products
    Industrials

    $AHT
    $AMD
    $AMSC
    $ASH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Crespo Jose Luis bought $87,282 worth of shares (37,300 units at $2.34), increasing direct ownership by 14% to 307,332 units (SEC Form 4)

    4 - PLUG POWER INC (0001093691) (Issuer)

    12/17/25 9:06:21 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Director Watson W. Mark bought $8,185 worth of shares (20,000 units at $0.41), increasing direct ownership by 19% to 124,125 units (SEC Form 4)

    4 - Vaxart, Inc. (0000072444) (Issuer)

    12/5/25 5:46:47 PM ET
    $VXRT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Heron Elaine J bought $15,921 worth of shares (40,000 units at $0.40), increasing direct ownership by 71% to 96,566 units (SEC Form 4)

    4 - Vaxart, Inc. (0000072444) (Issuer)

    11/21/25 1:21:51 PM ET
    $VXRT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Guo Yanru

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:44:35 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    New insider Wang Erqi claimed ownership of 4,306,307 units of Class A Ordinary Shares and claimed ownership of 1,000,000 units of Class B Ordinary Shares (SEC Form 3)

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:43:55 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    SEC Form 3 filed by new insider Wang Ziqiang

    3 - Jin Medical International Ltd. (0001837821) (Issuer)

    4/24/26 10:42:49 AM ET
    $ZJYL
    Industrial Specialties
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    SEC Filings

    View All

    SEC Form 6-K filed by Nomura Holdings Inc ADR

    6-K - NOMURA HOLDINGS INC (0001163653) (Filer)

    4/24/26 7:41:34 AM ET
    $NMR
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 6-K filed by Nomura Holdings Inc ADR

    6-K - NOMURA HOLDINGS INC (0001163653) (Filer)

    4/24/26 6:09:56 AM ET
    $NMR
    Investment Bankers/Brokers/Service
    Finance

    Vaxart Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Vaxart, Inc. (0000072444) (Filer)

    4/23/26 4:45:14 PM ET
    $VXRT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Advanced Micro Devices upgraded by DA Davidson with a new price target

    DA Davidson upgraded Advanced Micro Devices from Neutral to Buy and set a new price target of $375.00

    4/24/26 7:59:47 AM ET
    $AMD
    Semiconductors
    Technology

    KeyBanc Capital Markets reiterated coverage on Alphabet A with a new price target

    KeyBanc Capital Markets reiterated coverage of Alphabet A with a rating of Overweight and set a new price target of $380.00 from $370.00 previously

    4/20/26 9:39:07 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Bernstein reiterated coverage on Advanced Micro Devices with a new price target

    Bernstein reiterated coverage of Advanced Micro Devices with a rating of Mkt Perform and set a new price target of $265.00 from $235.00 previously

    4/16/26 12:58:56 PM ET
    $AMD
    Semiconductors
    Technology

    $AHT
    $AMD
    $AMSC
    $ASH
    Leadership Updates

    Live Leadership Updates

    View All

    Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

    Appointment strengthens Board's clinical development and regulatory expertise as Vaxart advances its oral vaccine platform SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX:VXRT), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary delivery platform, today announced the appointment of James Breitmeyer, M.D., Ph.D., to its Board of Directors. Dr. Breitmeyer brings more than 35 years of biopharmaceutical experience, having led clinical development programs resulting in eight FDA product approvals and numerous regulatory successes across the United States, Europe, and Japan. "We are pleased to welcome Jim to t

    4/23/26 4:30:00 PM ET
    $VXRT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    LSB Industries, Inc. Appoints Jonathan Ackerman as an Independent Member of the Board of Directors; Announces Retirement of Steve Packebush

    LSB Industries, Inc. ("LSB" or "the Company"), (NYSE:LXU) today announced that it has appointed Jonathan Z. Ackerman as an independent member of the Board of Directors (the "Board") effective April 2, 2026. Mr. Ackerman will stand for direct election by shareholders for the first time at the annual meeting of stockholders on May 21, 2026 (the "2026 Annual Meeting"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402484774/en/Jonathan Ackerman Mr. Ackerman has a lengthy track record as a successful leader in infrastructure development and finance. He has successfully delivered approximately $10 billion of value for investors b

    4/2/26 5:38:00 PM ET
    $LXU
    Major Chemicals
    Basic Materials

    GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

    GE HealthCare (NASDAQ:GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE:SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities. "Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and s

    3/17/26 9:00:00 AM ET
    $GEHC
    $SYK
    Medical Electronics
    Health Care
    Medical/Dental Instruments

    $AHT
    $AMD
    $AMSC
    $ASH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by DocGo Inc.

    SC 13D/A - DocGo Inc. (0001822359) (Subject)

    11/29/24 4:14:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Minim Inc.

    SC 13D/A - MINIM, INC. (0001467761) (Subject)

    11/15/24 5:00:07 PM ET
    $MINM
    Telecommunications Equipment
    Utilities

    Amendment: SEC Form SC 13D/A filed by Solid Biosciences Inc.

    SC 13D/A - Solid Biosciences Inc. (0001707502) (Subject)

    11/14/24 7:59:25 PM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHT
    $AMD
    $AMSC
    $ASH
    Financials

    Live finance-specific insights

    View All

    Rockwell Automation to Report Second Quarter Fiscal 2026 Results

    Rockwell Automation, Inc. (NYSE:ROK) is scheduled to report its second quarter fiscal 2026 results on Tuesday, May 5, before the market opens. The release will be posted on the Rockwell Investor Relations website at www.rockwellautomation.com/en-us/investors.html. A conference call to discuss the quarterly results will be held at 7:30 a.m. CDT on May 5. This call will be audio webcast and accessible on the Rockwell Automation Investor Relations website. Presentation materials will also be available on the website prior to the call. Interested parties can access the conference call by dialing the following numbers: (888) 330-2022 in North America; (365) 977-0051 in Canada; +1 (646) 960-0

    4/21/26 7:00:00 AM ET
    $ROK
    Industrial Machinery/Components
    Industrials

    MarketAxess to Host Conference Call Announcing First Quarter 2026 Financial Results on Thursday, May 7, 2026

    MarketAxess Holdings Inc. (NASDAQ:MKTX) the operator of a leading electronic trading platform for fixed-income securities, will issue a press release announcing its first quarter 2026 financial results on Thursday, May 7, 2026, before the market opens. Chris Concannon, Chief Executive Officer, and Ilene Fiszel Bieler, Chief Financial Officer, will host a conference call to provide a strategic update and discuss the Company's financial results and outlook on Thursday, May 7, 2026 at 10:00 a.m. ET. To access the conference call, please dial +1-800-715-9871 (U.S.) or +1-646-307-1963 (International) and use the ID 1832176. The Company will also host a live audio Webcast of the conference call

    4/20/26 4:30:00 PM ET
    $MKTX
    Investment Bankers/Brokers/Service
    Finance

    Powell Industries Announces Date and Conference Call for Fiscal 2026 Second Quarter Results

    HOUSTON, April 20, 2026 (GLOBE NEWSWIRE) --  Powell Industries, Inc. (NASDAQ:POWL), a leading supplier of custom engineered solutions for the management, control and distribution of electrical energy, today announced that it will release results for the fiscal second quarter ended March 31, 2026 on Monday, May 4, 2026 after the market closes. In conjunction with the release, Powell Industries has scheduled a conference call, which will be broadcast live within the Investor Relations section of the Company's website, on Tuesday, May 5, 2026 at 11:00 a.m. eastern time. What:Powell Industries Fiscal 2026 Q2 Earnings Conference Call  When:Tuesday, May 5, 2026 – 11:00 a.m. eastern / 10:00 a.m.

    4/20/26 4:15:00 PM ET
    $POWL
    Electrical Products
    Energy